Literature DB >> 6843288

Naloxone hyperalgesia and stress-induced analgesia in rats.

T J Coderre, G B Rollman.   

Abstract

Since past studies concerning the effects of naloxone on nociception have yielded inconclusive findings, the variables of pain test, baseline sensitivity, and stress condition were examined. Within a pure-bred strain of rats, consistent individual differences did not occur. All three measures of pain responsiveness demonstrated hyperalgesic effects of naloxone, but they differed in their capacity to reflect the effects of analgesia produced by continuous or intermittent electrical shock. By some measures, naloxone reversed the stress-induced analgesia due to intermittent shock; it did not influence the analgesia produced by continuous stress. The data support a model of pain inhibition involving both opioid and non-opioid systems and suggest that the hyperalgesic effects of naloxone can sometimes give rise to erroneous conclusions concerning apparent naloxone-reversability of putative analgesic procedures.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6843288     DOI: 10.1016/0024-3205(83)90103-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  21 in total

1.  Role of CD38, a cyclic ADP-ribosylcyclase, in morphine antinociception and tolerance.

Authors:  Lynn C Hull; Christopher Rabender; Bichoy H Gabra; Fan Zhang; Pin-Lan Li; William L Dewey
Journal:  J Pharmacol Exp Ther       Date:  2010-06-15       Impact factor: 4.030

2.  Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivity.

Authors:  Yunyun Yuan; Saheem A Zaidi; Orgil Elbegdorj; Lindsey C K Aschenbach; Guo Li; David L Stevens; Krista L Scoggins; William L Dewey; Dana E Selley; Yan Zhang
Journal:  J Med Chem       Date:  2013-11-07       Impact factor: 7.446

3.  Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice.

Authors:  Bichoy H Gabra; Chris P Bailey; Eamonn Kelly; Forrest L Smith; Graeme Henderson; William L Dewey
Journal:  Brain Res       Date:  2008-04-24       Impact factor: 3.252

4.  Nanoconjugated NAP as a Potent and Periphery Selective Mu Opioid Receptor Modulator To Treat Opioid-Induced Constipation.

Authors:  Guoyan G Xu; Olga Yu Zolotarskaya; Dwight A Williams; Yunyun Yuan; Dana E Selley; William L Dewey; Hamid I Akbarali; Hu Yang; Yan Zhang
Journal:  ACS Med Chem Lett       Date:  2016-11-21       Impact factor: 4.345

5.  Ethanol Reversal of Tolerance to the Antinociceptive Effects of Oxycodone and Hydrocodone.

Authors:  Joanna C Jacob; Justin L Poklis; Hamid I Akbarali; Graeme Henderson; William L Dewey
Journal:  J Pharmacol Exp Ther       Date:  2017-04-25       Impact factor: 4.030

6.  Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligands.

Authors:  Yunyun Yuan; Saheem A Zaidi; David L Stevens; Krista L Scoggins; Philip D Mosier; Glen E Kellogg; William L Dewey; Dana E Selley; Yan Zhang
Journal:  Bioorg Med Chem       Date:  2015-03-06       Impact factor: 3.641

7.  "Paradoxical" analgesia induced by naloxone and naltrexone.

Authors:  J D Greeley; A D Lê; C X Poulos; H Cappell
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia.

Authors:  Z H Galina; A J Kastin
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

9.  The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy.

Authors:  L C Hull; J Llorente; B H Gabra; F L Smith; E Kelly; C Bailey; G Henderson; W L Dewey
Journal:  J Pharmacol Exp Ther       Date:  2009-12-14       Impact factor: 4.030

10.  Plasma beta-endorphin levels in oral surgery patients following diazepam, fentanyl or placebo.

Authors:  K M Hargreaves
Journal:  Anesth Prog       Date:  1984 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.